Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2016, Article ID 3439419, 7 pages
http://dx.doi.org/10.1155/2016/3439419
Research Article

Preparation, Characterization, and In Vitro and Vivo Antitumor Activity of Oridonin-Conjugated Multiwalled Carbon Nanotubes Functionalized with Carboxylic Group

Department of Pharmaceutical Engineering, Institute of Chemical Engineering, Nanjing University of Science and Technology, Nanjing 210094, China

Received 5 December 2015; Revised 18 April 2016; Accepted 26 July 2016

Academic Editor: Ester Vazquez

Copyright © 2016 Chuanjin Wang and Wei Li. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. C. Meade-Tollin, E. M. K. Wijeratne, D. Cooper et al., “Ponicidin and oridonin are responsible for the antiangiogenic activity of Rabdosia rubescens, a constituent of the herbal supplement PC SPES,” Journal of Natural Products, vol. 67, no. 1, pp. 2–4, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. Q.-B. Han, M.-L. Li, S.-H. Li, Y.-K. Mou, Z.-W. Lin, and H.-D. Sun, “Ent-kaurane diterpenoids from Isodon rubescens var. lushanensis,” Chemical and Pharmaceutical Bulletin, vol. 51, no. 7, pp. 790–793, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. J.-X. Zhang, Q.-B. Han, A.-H. Zhao, and H.-D. Sun, “Diterpenoids from Isodon japonica,” Fitoterapia, vol. 74, no. 5, pp. 435–438, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Ikezoe, S. S. Chen, X. J. Tong, D. Heber, H. Taguchi, and H. Koeffler, “Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells,” International Journal of Oncology, vol. 23, no. 4, pp. 1187–1193, 2003. View at Publisher · View at Google Scholar
  5. S. Sheng, N. Bai, and C. S. Yang, “New cancer chemoprevention agents found from herbal medicine and functional food,” in Proceedings of the 227th American Chemical Society National Meeting, vol. 226, pp. 105–107, Anaheim, Calif, USA, April 2004.
  6. O. Regev, Y. Barenholz, S. Peretz, D. Zucker, and Y. Bavli-Felsen, “Can carbon nanotube-liposome conjugates address the issues associated with carbon nanotubes in drug delivery?” Future Medicinal Chemistry, vol. 5, no. 5, pp. 503–505, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Abbaszadeh, O. Moradi, M. Norouzi, and O. Sabzevari, “Improvement single-wall carbon nanotubes (SWCNTs) based on functionalizing with monomers 2-hydroxyethylmethacryate (HEMA) and N-vinylpyrrolidone (NVP) for pharmaceutical applications as cancer therapy,” Journal of Industrial and Engineering Chemistry, vol. 20, no. 5, pp. 2895–2900, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Vardharajula, S. Z. Ali, P. M. Tiwari et al., “Functionalized carbon nanotubes: biomedical applications,” International Journal of Nanomedicine, vol. 7, pp. 5361–5374, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Tan, G. Karthivashan, P. Arulselvan, S. Fakurazi, and M. Z. Hussein, “Characterization and in vitro studies of the anticancer effect of oxidized carbon nanotubes functionalized with betulinic acid,” Drug Design, Development and Therapy, vol. 8, pp. 2333–2343, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Nakayama-Ratchford, S. Bangsaruntip, X. Sun, K. Welsher, and H. Dai, “Noncovalent functionalization of carbon nanotubes by fluorescein- polyethylene glycol: supramolecular conjugates with pH-dependent absorbance and fluorescence,” Journal of the American Chemical Society, vol. 129, no. 9, pp. 2448–2449, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. C. J. Wang, Y. Y. Wei, L. Yu, and L. Zhang, “The effect of stealth liposomes on pharmacokinetics, tissue distribution and anti-tumor activity of oridonin,” PDA Journal of Pharmaceutical Science and Technology, vol. 63, no. 5, pp. 409–416, 2009. View at Google Scholar · View at Scopus
  12. Y.-F. Yuan, X.-Y. Hu, Y. He, and J.-G. Deng, “Synthesis and anti-tumor activity evaluation of rhein-aloe emodin hybrid molecule,” Natural Product Communications, vol. 7, no. 2, pp. 207–210, 2012. View at Google Scholar · View at Scopus
  13. N. W. S. Kam and H. Dai, “Single walled carbon nanotubes for transport and delivery of biological cargos,” Physica Status Solidi (B), vol. 243, no. 13, pp. 3561–3566, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Patlolla, B. Knighten, and P. Tchounwou, “Multi-walled carbon nanotubes induce cytotoxicity, genotoxicity and apoptosis in normal human dermal fibroblast cells,” Ethnicity & Disease, vol. 20, no. 1, pp. S1-65–S1-72, 2010. View at Google Scholar · View at Scopus
  15. H. Y. Xu, J. Meng, and H. Kong, “What are carbon nanotubes' roles in anti-tumor therapies?” Science China Chemistry, vol. 53, no. 11, pp. 2250–2256, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Wu, R. Li, X. Bian et al., “Covalently combining carbon nanotubes with anticancer agent: preparation and antitumor activity,” ACS Nano, vol. 3, no. 9, pp. 2740–2750, 2009. View at Publisher · View at Google Scholar · View at Scopus